热门资讯> 正文
Dogwood Therapeutics重新与纳斯达克合规
2025-04-03 21:08
- Dogwood Therapeutics (NASDAQ:DWTX) said it has regained compliance with the minimum stockholders’ equity requirement.
- “The company has a strong cash position of $17.5 million as of the end of Q1, with no debt, better positioning the company to advance its continued mission to build shareholder value," said CEO Greg Duncan.
More on Dogwood Therapeutics
- Dogwood Therapeutics announces pricing of $4.8 million offering
- Dogwood Therapeutics announces conversion of existing $19.5M in debt to equity
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
